Journal of Applied Microbiology · 2011 · 56 citations · 26 references
MedicineInfectious DiseasesPharmacologyImmunopathologyInflammationInnate ImmunityAntibacterial PharmacologyBacterial PathogenesisInflammation In Infectious DiseasePulmonary InfectionsLactate Dehydrogenase Release AssaysMurine ModelsPneumonia PathologyProtective TreatmentsReal-time Polymerase Chain Reaction (Pcr)Respiratory Epithelium InjuryWestern Blot Analysis
AIM: To elucidate the effect of chrysin on α-haemolysin production by Staphylococcus aureus and protection against pneumonia in a murine model. METHODS AND RESULTS: Haemolysis, Western blot and real-time RT-PCR assays were performed to evaluate the effect of chrysin on α-haemolysin secretion by Staph. aureus. The efficacy of chrysin against human alveolar epithelial cell injury by α-haemolysin was tested using live/dead staining or by measuring lactate dehydrogenase activity. Furthermore, we determined the protective effect of chrysin against Staph. aureus pneumonia through histopathology experiments in a mouse model. The production of α-haemolysin by Staph. aureus was inhibited when presented with an increasing subinhibitory concentration of chrysin in vitro. Consistent with this result, chrysin prevented α-haemolysin-mediated cell injury and protected mice from Staph. aureus pneumonia. CONCLUSIONS: Chrysin is a potent inhibitor of α-haemolysin expression by Staph. aureus, and it conferred a significant degree of protection against Staph. aureus pneumonia. SIGNIFICANCE AND IMPACT OF STUDY: The chrysin-mediated inhibition of α-haemolysin production and protection against Staph. aureus pneumonia may offer a new strategy in combating pathogen infections.
26
Performance standards for antimicrobial susceptibility testing
Mary Jane Ferraro · 2001 · 9.8K citations
Epidemiology and Outcomes of Health-care–Associated Pneumonia
Marin H. Kollef, Andrew F. Shorr, Ying P. Tabak et al. · CHEST Journal · 2005 · 951 citations